Theriva Biologics Inc (TOVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1996 | 12-1993 | 12-1992 | 12-1991 | 12-1990 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,980 | 1,682 | 200 | 198 | 198 |
| Marketable Securities | 461 | 0 | 0 | 0 | 0 |
| Receivables | N/A | 1 | 3 | 0 | 0 |
| Other current assets | 44 | 49 | 2 | 166 | 166 |
| TOTAL | $2,485 | $1,732 | $205 | $364 | $364 |
| Non-Current Assets | |||||
| PPE Net | 174 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 103 | 251 | 0 | 0 |
| TOTAL | $174 | $103 | $251 | $N/A | $N/A |
| Total Assets | $2,774 | $1,835 | $455 | $364 | $364 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 0 | 162 | 197 | 8 | 8 |
| TOTAL | $1,051 | $162 | $197 | $42 | $42 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 750 | 0 | 0 |
| TOTAL | $N/A | $N/A | $750 | $N/A | $N/A |
| Total Liabilities | $1,051 | $162 | $947 | $42 | $42 |
| Shareholders' Equity | |||||
| Common Shares | 114 | 7,291 | 1,505 | 365 | 365 |
| Retained earnings | N/A | -5,872 | -1,996 | -44 | -44 |
| Other shareholders' equity | 1,582 | 0 | 0 | 0 | 0 |
| TOTAL | $1,696 | $1,673 | $-492 | $322 | $322 |
| Total Liabilities And Equity | $2,747 | $1,835 | $455 | $364 | $364 |